Table 2.
Baseline characteristics of patients with multiple sclerosis (MS), other neurological disease (OND), and healthy controls (HC).
| MS (n=24) |
OND (n=23) |
HC (n=24) |
P value | |
|---|---|---|---|---|
| Age (years) | 35.2 ± 5.3 | 36.7 ± 5.9 | 35.0 ± 6.5 | 0.533 |
| Sex (male / female) | 15/19 | 16/17 | 16/18 | 0.904 |
| Disease course (years) | 2.5 ± 1.3 | – | – | – |
| EDSS | 1.9 ± 1.4 | – | – | – |
| HLA-A*03:01 [n (%)] | 24 (100%) | 23 (100%) | 24 (100%) | 0.999 |
| Leukocyte (× 103/μl) | 5.70 ± 1.75 | 6.72 ± 1.62 | 6.53 ± 1.56 | 0.086 |
| Neutrophils (× 103/μl) | 3.76 ± 1.28 | 4.39 ± 1.08 | 4.36 ± 1.44 | 0.162 |
| Lymphocytes (× 103/μl) | 1.63 ± 0.54 | 1.62 ± 0.61 | 1.84 ± 0.48 | 0.298 |
| Monocytes (× 103/μl) | 0.35 ± 0.08 | 0.41 ± 0.11 | 0.39 ± 0.13 | 0.101 |
| Eosinophils (× 103/μl) | 0.07 ± 0.51 | 0.18 ± 0.14 | 0.11 ± 0.08 | 0.201 |
| Basophils (× 103/μl) | 0.02 ± 0.01 | 0.03 ± 0.01 | 0.02 ± 0.01 | 0.092 |
Data are mean ± SD. EDSS, The Expanded Disability Status Scale.